# NGS and TME for Evidence-based Treatment of Pancreatic Cancer

> **NCT02767700** · — · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 39 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **GENETIC:** NGS

## Key facts

- **NCT ID:** NCT02767700
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-03-25
- **Final completion:** 2018-08-31
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767700, "NGS and TME for Evidence-based Treatment of Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02767700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*